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B R I E F  R E P O R T
Severe Rhabdomyolysis Associated 
With RSV
James Bender,1 Rusheng Chew,2 Belinda Bin Lin,2 and Eugene Athan3
1Junior Medical Workforce, Barwon Health, Geelong, Australia; 2Department of Infectious 
Diseases, Barwon Health, Geelong, Australia; 3Department of Infectious Diseases, Barwon 
Health, Deakin University, Geelong, Australia
Severe rhabdomyolysis is associated with morbidity and mor-
tality. We report on a previously well male who developed 
severe rhabdomyolysis, sepsis, and multi-organ failure. The pa-
tient made a complete recovery. Extensive microbiological test-
ing was only positive for RSV, making this the first reported case 
of adult RSV-related rhabdomyolysis in the literature.




A 42-year-old male presented to the University Hospital Geelong, 
Victoria, Australia, with a 2-day history of generalized myalgia, 
dyspnoea, cough, headache, chills, and fever. He was a well and 
active individual with no significant past medical history. He 
was a smoker, consuming 20 cigarettes per day on a background 
of at least 10 years of variable smoking intensity, but consumed 
minimal alcohol. He had a BMI of 33 kg/m2, putting him in the 
obese range. Using BMI as a marker of adiposity in this patient 
was limited by his large muscle mass, and adiposity was not 
deemed to be a significant risk factor. His wife and children had 
been unwell in the week prior to his presentation, with upper 
respiratory tract symptoms, but they had all recovered. Further 
questioning revealed significant exposure to animal excretions 
in the course of his work as a carpet layer. He was a keen fisher-
man who ate his catch and regularly hunted rabbits and foxes.
On admission, his respiratory status rapidly deteriorated, 
with increasing work of breathing and oxygen requirements. 
Within 24 hours, he was admitted to the intensive care unit 
(ICU). In the ICU, his initial observations showed a blood 
pressure of 210/130 mmHg, which rapidly deteriorated to a sys-
tolic blood pressure of 90 mmHg, heart rate of 110, oxygen sat-
uration of 88% breathing air, and respiratory rate of 30 breaths/
minute. He was mechanically ventilated on an inspired oxygen 
fraction of 100% and required significant vasopressor support. 
He became anuric within 24 hours and required hemofiltration. 
His initial chest radiograph was suggestive of viral pneumonitis.
Initial blood tests showed a significant leukocytosis with a 
white cell count of 33.0 × 109/L (4.0–11.0 × 109/L) and predom-
inant neutrophilia. He was also thrombocytopenic with a plate-
let count of 95 × 109/L (150–500 109/L). His C-reactive protein 
(CRP) was elevated to 55  mg/L (<2.9), lactate to 8.2  mmol/L 
(<2), and he had a severe metabolic acidosis with pH 7.11. His 
alanine aminotransferase (ALT) peaked at 4351 U/L, and aspar-
tate aminotransferase (AST) at 9209 U/L on day 3 of admission. 
His creatine kinase (CK) levels were markedly raised, with ini-
tial testing showing levels of 26 302 U/L (39–308 U/L). His CK 
increased dramatically in the following days, peaking at 330 110 
U/L on day 4.  This CK level combined with the presence of 
myoglobinuria in the ultrafiltrate bags indicated extreme rhab-
domyolysis. Blood and urine cultures, and urine antigen for 
Legionella pneumophila type 1 and Streptococcus pneumoniae, 
were negative.
Initial management was supportive, with broad spectrum 
antibiotic coverage of azithromycin and ceftriaxone being 
commenced empirically on the day of presentation. The ini-
tial working diagnosis was severe community-acquired pneu-
monia, with viral pneumonitis considered a differential. This 
initial treatment was broadened when he failed to improve, 
to include courses of ciprofloxacin, meropenem, vancomycin, 
clindamycin, and oseltamivir.
An extensive workup was performed, including acute and 
convalescent serology for Epstein-Barr virus (EBV), cyto-
megalovirus (CMV), herpes simplex virus (HSV), human im-
munodeficiency virus (HIV), hepatitis B and C, adenovirus, 
Ross-River virus (RRV), influenza, Chlamydia pneumoniae, 
Q-fever, Legionella, Brucella, Mycoplasma, and Leptospira spe-
cies. These were all negative. Screening IgM for Leptospira spe-
cies was positive; however, this was not confirmed in both acute 
and convalescent samples by microscopic agglutination for 
the 9 strains tested in Victoria, and therefore was regarded as 
a false-positive result. Serum polymerase chain reaction (PCR) 
for HSV and CMV were also negative. Cultures from blood, 
bone marrow aspirate, sputum, and urine were negative for 
pathogens. Sputum multiplex PCR was negative for Legionella 
spp, Mycoplasma spp, Chlamydiaeceae, Bordetella pertussis, and 
B. parapertussis. A naso-pharyngeal swab for respiratory viral 
PCR detected RSV, but was negative for influenza. A computed 
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tomography (CT) scan was completed on his abdomen and 
pelvis, which showed liver congestion and widespread muscle 
edema (Figure 1). Due to the muscle edema and extensive CK 
rise, a muscle biopsy was completed, which showed no micro-
scopic abnormality and was nondiagnostic. PCR for influenza, 
parainfluenza, rhinovirus, adenovirus, metapneumovirus, RSV, 
enterovirus, parechovirus, EBV, CMV, varicella-zoster virus, 
and HSV done on the tissue biopsy specimen was negative.
He required 15 days in the ICU, during 9 of which he was 
sedated and required mechanical ventilation. Due to shock, he 
received high-dose inotropic support, and he required hemofil-
tration due to acute kidney injury, anuria, and a profound meta-
bolic acidosis. Antibiotics were ceased on day 16.
After discharge from the ICU, he required extensive inpatient 
rehabilitation with ongoing hemodialysis. He made a good re-
covery and was discharged home after 14 days of inpatient re-
habilitation, ceasing dialysis shortly after discharge.
DISCUSSION
Rhabdomyolysis is a clinical syndrome characterized by muscle 
necrosis and the release of muscle constituents into circulation. 
The traditional characteristics of rhabdomyolysis include my-
algia and weakness, and are often associated with dark urine 
that results from myoglobin excretion [1]. Rhabdomyolysis 
ranges in severity from asymptomatic to life threatening, and 
complications such as acute kidney injury are more likely to 
occur with higher CK levels and associated sepsis and acid-
osis [2, 3]. While the mortality of rhabdomyolysis is variably 
reported in the literature, it is accepted that mortality is greater 
if rhabdomyolysis is associated with acute kidney injury [4], and 
it has been reported as high as 59% in those with acute kidney 
injury requiring ICU admission [3].
The etiology of rhabdomyolysis is variable and includes 
infection, trauma, toxins, extreme exertion, prolonged immo-
bilization, drugs and medications, and metabolic diseases [5]. 
We hypothesized infection to be the most likely cause of our 
patient’s rhabdomyolysis, as his presentation was suggestive of 
a respiratory viral infection and his family had recently been 
unwell with upper respiratory tract symptoms. Toxins were con-
sidered a differential, with many toxins including snake, spider, 
and bee venom, as well as carbon monoxide, being associated 
with rhabdomyolysis [5, 6]. A rarer cause of rhabdomyolysis is 
that induced by an unidentified toxin associated with fish diges-
tion, known as Haff disease [7]. While our patient regularly eats 
his own catch, his family had not become ill despite eating the 
same fish. The other causes of toxin-related rhabdomyolysis 
were excluded after taking a thorough history, which failed to 
identify exposure to other toxins.
Infectious causes can be bacterial, viral, parasitic, or fungal 
in origin. The most common bacterial pathogens identified in 
the literature are Legionella spp, followed by Francisella and 
Streptococcal spp [8, 9]. Singh and Scheld documented creatine 
kinase levels associated with infection from different pathogens 
[8]. The only bacterial pathogens to cause levels greater than 
300 000 U/L, similar to our patient, were Legionella, Francisella, 
Brucella, and Leptospira spp [8]. Leptospirosis was a differential 
diagnosis in our patient due to his recent exposure to animal 
urine combined with an increase in leptospirosis notifications 
in Victoria in 2016 [10]. This diagnosis was excluded on sero-
logical testing.
Viral causes of rhabdomyolysis are more common than 
bacterial [9]. Influenza is the most common viral pathogen, 
followed by HIV and coxsackie virus [8, 9]. Viral causes of rhab-
domyolysis also appear to correlate with higher creatine kinase 
levels (>300 000 U/L) [8]. Our patient received extensive viral 
testing, and only returned a positive result for RSV.
There have been only 2 documented cases of RSV-induced 
rhabdomyolysis, both in pediatric patients. The first case was 
in a 2-year-old previously healthy boy who had RSV diagnosed 
by enzyme-linked immunosorbent assay in a nasopharyngeal 
Figure 1. Increased psoas muscle size at time of raised creatinine suggestive of edema, and edematous lower limb muscle with inflammatory stranding.
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sample [11]. The patient was referred to the hospital after 10 days 
of nonspecific symptoms including diarrhea, sore throat, fever, 
generalized myalgia, and weakness. Investigations showed sig-
nificant CK elevation (55 000 U/L) as well as liver dysfunction 
with ALT elevation to 1198 U/L (10–60 U/L) and AST to 4065 
U/L (10–55 U/L). While these are nonspecific findings, this case 
has a number of similarities to our patient, whose ALT peaked 
at 4351 U/L and AST at 9209 U/L 3 days after admission, and 
who also presented with fever, myalgia, weakness, and respira-
tory symptoms. The second case is documented in a German 
report of RSV rhabdomyolysis in a 4-month-old child [12]. This 
case also had similarities to ours, in that the child suffered acute 
renal failure and hepatic dysfunction.
Our case is significant as it is the first documented case of 
severe rhabdomyolysis associated with RSV infection in an 
adult. RSV is often a self-limiting disease in adults, and is more 
commonly known for causing severe illness in infants. Despite 
this, our patient’s history of respiratory symptoms, a recent 
viral respiratory infection in his family, a lack of any other clear 
diagnosis, and only testing positive for RSV among a battery of 
investigations suggest that this is the first documented case of 
RSV-associated rhabdomyolysis in an adult patient.
CONCLUSION
We have reported on a severe case of RSV-associated rhab-
domyolysis in a previously healthy 42-year-old male. It is the 
first documented case of severe rhabdomyolysis related to RSV 
in an adult patient, and only the third case in a patient of any 
age that can be found in the literature. While a rare cause of 
rhabdomyolysis, RSV should be considered a possible etio-
logical agent in a patient with rhabdomyolysis and symptoms of 
respiratory tract infection.
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